<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00252694</url>
  </required_header>
  <id_info>
    <org_study_id>D2453C00047</org_study_id>
    <secondary_id>DIRECT</secondary_id>
    <secondary_id>SH-AHM-0047</secondary_id>
    <nct_id>NCT00252694</nct_id>
  </id_info>
  <brief_title>DIabetic Retinopathy Candesartan Trials</brief_title>
  <acronym>DIRECT</acronym>
  <official_title>Effects of Candesartan Cilexetil (Candesartan) on Diabetic Retinopathy in Type 2 Diabetic Patients With Retinopathy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Takeda</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>AstraZeneca</source>
  <brief_summary>
    <textblock>
      The primary objective is to determine whether candesartan, compared to placebo reduces the
      progression of diabetic retinopathy in normoalbuminuric type 2 diabetic patients with
      retinopathy.

      The secondary objective is to determine whether candesartan, compared to placebo, reduces the
      incidence of clinically significant macular oedema (CSME) and/or proliferative diabetic
      retinopathy (PDR) and beneficially influences the rate change in urinary albumin excretion
      rate (UAER).

      This study is part of the DIRECT Programme also including a primary prevention study of
      diabetic retinopathy in type 1 diabetes and a secondary prevention study in type 1 diabetes.
      The primary objective for all three pooled studies is to determine whether candesartan,
      compared to placebo, reduces the incidence of microalbuminuria in type 1 and type 2 diabetic
      patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2001</start_date>
  <completion_date type="Actual">April 2008</completion_date>
  <primary_completion_date type="Actual">February 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With a 3-step or Greater Increase in Early Treatment of Diabetic Retinopathy Study (EDTRS) Severity Scale</measure>
    <time_frame>From baseline to end of study, i.e. 5 years, with visits after a half year, one year and thereafter one visit per year.</time_frame>
    <description>3 steps were defined as either a 1-step change in one eye and a 2-step change in the other eye or as a 3-step change in one eye only. EDRTS is a scale with 11 steps (1-11). A generlized log-rank test was used to test difference between treatments.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With at Least a 3 Step Improvement or a Persistent 2-step Improvement in the ETDRS Severity Scale.</measure>
    <time_frame>From baseline to end of study, i.e. 5 years.</time_frame>
    <description>3 steps were defined as either a 1-step change in one eye and a 2-step change in the other eye or as a 3-step change in one eye only. EDRTS is a scale with 11 steps (1-11).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Incident Clinically Significant Macular Edema (CSME) and/or Proliferative Diabetic Retinopathy (PDR).</measure>
    <time_frame>From baseline to end of study, i.e. 5 years.</time_frame>
    <description>Clinically Significant Macular Edema (CSME) and Proliferative Diabetic Retinopathy (PDR) are diagnosed via retinal photographs.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of Change in Urinary Albumin Excretion Rate (UAER).</measure>
    <time_frame>From Baseline to end of study, i.e. 5 years.</time_frame>
    <description>An estimate of the slope from fitting a linear regression of log(UAER) over time (post-randomisation, yearly assessments) for each patient.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">4717</enrollment>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>candesartan</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>candesartan cilexetil 32 mg once daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>control</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>candesartan</intervention_name>
    <description>32 mg oral tablet</description>
    <arm_group_label>candesartan</arm_group_label>
    <other_name>ATACAND</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female aged 37 - 75 years with type 2 diabetes diagnosed at age of 36 years or
             thereafter.

          -  Duration of diabetes for &gt; 1 year and &lt; 20 years with stable diabetic therapy within
             last 6 months.

          -  Patients with untreated resting mean sitting SBP &lt; 130 mmHg and mean sitting DBP &lt; 85
             or treated resting mean SBP &lt; 160 mmHg and mean sitting DBP &lt; 90 mmHg with retinal
             photograph grading level &gt;20/10 up to &lt; 47/47 (on ETDRS severity scale).

        Exclusion Criteria:

          -  Patients with the following conditions are excluded from participation in the study:

          -  Cataract or media opacity of a degree which precludes taking gradable retinal
             photographs

          -  Angle closure glaucoma, which precludes pharmacological dilatation of the pupil

          -  History of or presence of proliferative retinopathy

          -  History or presence of clinical significant macular oedema (CSME)

          -  History or evidence of photocoagulation of the retina

          -  Other retinal conditions which may mask assessment, eg, retinal vein occlusion

          -  Positive micral dipstick test

          -  Presence of secondary diabetes

          -  Pregnant or lactating women or women of child bearing potential not practicing an
             adequate method of contraception

          -  Need of treatment with ACE-inhibitor

          -  Haemodynamically significant aortic or mitral valve stenosis

          -  Known renal artery stenosis or kidney transplantation

          -  Hypersensitivity to study drug

          -  Severe concomitant disease which may interfere with the assessment of the patient, eg,
             malignancy, as judged by the investigator
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>37 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>AstraZeneca Atacand Medical Science Director, MD</last_name>
    <role>Study Director</role>
    <affiliation>AstraZeneca</affiliation>
  </overall_official>
  <link>
    <url>http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&amp;studyid=1912&amp;filename=CSR-D2453C00047.pdf</url>
    <description>CSR-D2453C00047.pdf</description>
  </link>
  <verification_date>April 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 10, 2005</study_first_submitted>
  <study_first_submitted_qc>November 14, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 15, 2005</study_first_posted>
  <results_first_submitted>March 22, 2012</results_first_submitted>
  <results_first_submitted_qc>May 9, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 6, 2014</results_first_posted>
  <last_update_submitted>May 9, 2014</last_update_submitted>
  <last_update_submitted_qc>May 9, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 6, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diabetes mellitus type 2</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Diseases</mesh_term>
    <mesh_term>Diabetic Retinopathy</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Candesartan</mesh_term>
    <mesh_term>Candesartan cilexetil</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>First subject enrolled in the DIRECT Programme 8 June 2001 and last subject completed the DIRECT Programme 16 April 2008 mainly in hospital based clinics. A total of 4717 patients enrolled into the programme of whom 1905 patients proceeded to randomization into Study 47.</recruitment_details>
      <pre_assignment_details>The most common reason for not being randomized was that all eligibility criteria were not fulfilled, followed by withdrawn informed consent.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Candesartan</title>
          <description>Candesartan cilexetil 32 mg once daily</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>Placebo Comparator</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="951"/>
                <participants group_id="P2" count="954"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="807"/>
                <participants group_id="P2" count="800"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="144"/>
                <participants group_id="P2" count="154"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="83"/>
                <participants group_id="P2" count="91"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="36"/>
                <participants group_id="P2" count="34"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Mostly Lost to Follow Up</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Patient Moving</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="16"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Candesartan</title>
          <description>Candesartan cilexetil 32 mg once daily</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>Placebo Comparator</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="951"/>
            <count group_id="B2" value="954"/>
            <count group_id="B3" value="1905"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="809"/>
                    <measurement group_id="B2" value="808"/>
                    <measurement group_id="B3" value="1617"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="142"/>
                    <measurement group_id="B2" value="146"/>
                    <measurement group_id="B3" value="288"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56.9" spread="7.6"/>
                    <measurement group_id="B2" value="56.8" spread="7.9"/>
                    <measurement group_id="B3" value="56.8" spread="7.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="485"/>
                    <measurement group_id="B2" value="472"/>
                    <measurement group_id="B3" value="957"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="466"/>
                    <measurement group_id="B2" value="482"/>
                    <measurement group_id="B3" value="948"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Russian Federation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="162"/>
                    <measurement group_id="B2" value="165"/>
                    <measurement group_id="B3" value="327"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Europe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="419"/>
                    <measurement group_id="B2" value="438"/>
                    <measurement group_id="B3" value="857"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Israel</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="188"/>
                    <measurement group_id="B2" value="173"/>
                    <measurement group_id="B3" value="361"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>South Africa</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="182"/>
                    <measurement group_id="B2" value="178"/>
                    <measurement group_id="B3" value="360"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With a 3-step or Greater Increase in Early Treatment of Diabetic Retinopathy Study (EDTRS) Severity Scale</title>
        <description>3 steps were defined as either a 1-step change in one eye and a 2-step change in the other eye or as a 3-step change in one eye only. EDRTS is a scale with 11 steps (1-11). A generlized log-rank test was used to test difference between treatments.</description>
        <time_frame>From baseline to end of study, i.e. 5 years, with visits after a half year, one year and thereafter one visit per year.</time_frame>
        <population>The population was the Intention To Treat population which includes all randomized patients with any post-randomization data.</population>
        <group_list>
          <group group_id="O1">
            <title>Candesartan</title>
            <description>Candesartan cilexetil 32 mg once daily</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo Comparator</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With a 3-step or Greater Increase in Early Treatment of Diabetic Retinopathy Study (EDTRS) Severity Scale</title>
          <description>3 steps were defined as either a 1-step change in one eye and a 2-step change in the other eye or as a 3-step change in one eye only. EDRTS is a scale with 11 steps (1-11). A generlized log-rank test was used to test difference between treatments.</description>
          <population>The population was the Intention To Treat population which includes all randomized patients with any post-randomization data.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="951"/>
                <count group_id="O2" value="954"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="161" spread="0.045"/>
                    <measurement group_id="O2" value="182" spread="0.052"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.1994</p_value>
            <method>Log Rank</method>
            <method_desc>Generalized</method_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.870</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.704</ci_lower_limit>
            <ci_upper_limit>1.076</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With at Least a 3 Step Improvement or a Persistent 2-step Improvement in the ETDRS Severity Scale.</title>
        <description>3 steps were defined as either a 1-step change in one eye and a 2-step change in the other eye or as a 3-step change in one eye only. EDRTS is a scale with 11 steps (1-11).</description>
        <time_frame>From baseline to end of study, i.e. 5 years.</time_frame>
        <population>The population was the Intention To Treat population which includes all randomized patients with any post-randomization data.</population>
        <group_list>
          <group group_id="O1">
            <title>Candesartan</title>
            <description>Candesartan cilexetil 32 mg once daily</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo Comparator</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With at Least a 3 Step Improvement or a Persistent 2-step Improvement in the ETDRS Severity Scale.</title>
          <description>3 steps were defined as either a 1-step change in one eye and a 2-step change in the other eye or as a 3-step change in one eye only. EDRTS is a scale with 11 steps (1-11).</description>
          <population>The population was the Intention To Treat population which includes all randomized patients with any post-randomization data.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="951"/>
                <count group_id="O2" value="954"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="180" spread="0.054"/>
                    <measurement group_id="O2" value="136" spread="0.040"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Incident Clinically Significant Macular Edema (CSME) and/or Proliferative Diabetic Retinopathy (PDR).</title>
        <description>Clinically Significant Macular Edema (CSME) and Proliferative Diabetic Retinopathy (PDR) are diagnosed via retinal photographs.</description>
        <time_frame>From baseline to end of study, i.e. 5 years.</time_frame>
        <population>The population was the Intention To Treat population which includes all randomized patients with any post-randomization data.</population>
        <group_list>
          <group group_id="O1">
            <title>Candesartan</title>
            <description>Candesartan cilexetil 32 mg once daily</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo Comparator</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Incident Clinically Significant Macular Edema (CSME) and/or Proliferative Diabetic Retinopathy (PDR).</title>
          <description>Clinically Significant Macular Edema (CSME) and Proliferative Diabetic Retinopathy (PDR) are diagnosed via retinal photographs.</description>
          <population>The population was the Intention To Treat population which includes all randomized patients with any post-randomization data.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="951"/>
                <count group_id="O2" value="954"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="192" spread="0.06"/>
                    <measurement group_id="O2" value="193" spread="0.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Rate of Change in Urinary Albumin Excretion Rate (UAER).</title>
        <description>An estimate of the slope from fitting a linear regression of log(UAER) over time (post-randomisation, yearly assessments) for each patient.</description>
        <time_frame>From Baseline to end of study, i.e. 5 years.</time_frame>
        <population>The population was the Intention To Treat population which includes all randomized patients with any post-randomization data.</population>
        <group_list>
          <group group_id="O1">
            <title>Candesartan</title>
            <description>Candesartan cilexetil 32 mg once daily</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo Comparator</description>
          </group>
        </group_list>
        <measure>
          <title>Rate of Change in Urinary Albumin Excretion Rate (UAER).</title>
          <description>An estimate of the slope from fitting a linear regression of log(UAER) over time (post-randomisation, yearly assessments) for each patient.</description>
          <population>The population was the Intention To Treat population which includes all randomized patients with any post-randomization data.</population>
          <units>log (Âµg/min)/1000 year</units>
          <param>Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="951"/>
                <count group_id="O2" value="954"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="656" lower_limit="605" upper_limit="708"/>
                    <measurement group_id="O2" value="718" lower_limit="666" upper_limit="770"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>During treatment.</time_frame>
      <desc>The population used was the Safety population which includes all patients who received at least 1 dose of randomized study drug and for whom any post-dose data were available.</desc>
      <group_list>
        <group group_id="E1">
          <title>Candesartan</title>
          <description>Candesartan cilexetil 32 mg once daily</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>Placebo Comparator</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 11.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="301" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="267" subjects_at_risk="953"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Disseminated Intravascular Coagulation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Iron Deficiency Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Myocardial Infarction</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Angina Pectoris</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Acute Myocardial Infarction</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Angina Unstable</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Coronary Artery Disease</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Atrial Fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Myocardial Ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Acute Coronary Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis Coronary Artery</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Cardiac Failure Congestive</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Coronary Artery Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Cardiac Failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Supraventricular Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Aortic Valve Incompetence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Aortic Valve Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Arrhythmia Supraventricular</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Atrial Flutter</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Atrioventricular Block Complete</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Cardiac Arrest</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Cardiac Disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Cardiogenic Shock</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Cardiovascular Disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Congestive Cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Coronary Artery Insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Coronary Artery Occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Intracardiac Thrombus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Ischaemic Cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Left Ventricular Failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Mitral Valve Disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Mitral Valve Incompetence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Nodal Arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Hydrocele</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Ventricular Septal Defect</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Tinnitus</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Vertigo Positional</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Deafness Neurosensory</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Sudden Hearing Loss</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Tympanic Membrane Perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Goitre</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Basedow's Disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Cushing's Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Thyroid Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Thyroiditis Chronic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Angle Closure Glaucoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Eye Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Glaucoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Open Angle Glaucoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Optic Ischaemic Neuropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Optic Nerve Cupping</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Retinal Artery Embolism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Retinal Detachment</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Retinal Tear</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Retinal Vein Occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Uveitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal Pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Anal Fistula</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Gastroduodenitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal Reflux Disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Inguinal Hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Pancreatitis Acute</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Abdominal Adhesions</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Abdominal Discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Colonic Polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Duodenal Polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Duodenal Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Epigastric Discomfort</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Erosive Oesophagitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Food Poisoning</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Gastric Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Hypomotility</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Haemorrhoidal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Intestinal Perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Oesophagitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Oesophagitis Ulcerative</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Peritonitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Sigmoiditis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Umbilical Hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Chest Pain</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Non-Cardiac Chest Pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Sudden Death</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Sudden Cardiac Death</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Cardiac Death</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Inflammation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Multi-Organ Failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Oedema Peripheral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Cholangitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Cholecystitis Acute</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Cholestasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Gallbladder Perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Hepatic Cirrhosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Hepatic Steatosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Hepatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Jaundice</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Sphincter Of Oddi Dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="953"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Postoperative Wound Infection</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Diabetic Foot Infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Perianal Abscess</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Diabetic Gangrene</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Gangrene</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Hepatitis C</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Lower Respiratory Tract Infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Viral Infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Abscess Limb</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Acute Tonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Bronchiectasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Bronchopneumonia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Cholecystitis Infective</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Epstein-Barr Virus Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Erysipelas</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Gastroenteritis Viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Herpes Zoster Ophthalmic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Hordeolum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Lobar Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Localised Infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Muscle Abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Osteomyelitis Chronic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Otitis Externa</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Otitis Media</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Paronychia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Pericarditis Infective</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Perineal Abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Post Procedural Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Salpingitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Scrotal Abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Subcutaneous Abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Toxic Shock Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Tuberculosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Viral Labyrinthitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Viral Pericarditis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Wound Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Ankle Fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Head Injury</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Road Traffic Accident</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Femur Fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Hand Fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Limb Injury</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Meniscus Lesion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Multiple Injuries</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Acetabulum Fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Alcohol Poisoning</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Asphyxia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Clavicle Fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Dislocation Of Joint Prosthesis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Dural Tear</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Epicondylitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Foot Fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Forearm Fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Hip Fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Humerus Fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Internal Injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Joint Dislocation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Joint Injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Multiple Fractures</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Muscle Injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Peroneal Nerve Injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Poisoning</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Postoperative Hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Rib Fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Soft Tissue Injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Spinal Compression Fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Spinal Fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Sternal Fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Tendon Injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Tendon Rupture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Tibia Fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Wrist Fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Red Blood Cell Sedimentation Rate Increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Diabetes Mellitus Inadequate Control</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Diabetic Foot</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Diabetic Ketoacidosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Iron Deficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Ketoacidosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Metabolic Acidosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Obesity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Back Pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Intervertebral Disc Disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Musculoskeletal Chest Pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Spinal Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Intervertebral Disc Protrusion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Musculoskeletal Pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Periarthritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Spinal Column Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Chondrocalcinosis Pyrophosphate</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Dupuytren's Contracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Foot Deformity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Intervertebral Disc Degeneration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Jaw Cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Myositis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Osteitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Osteoporosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Rheumatoid Arthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Rotator Cuff Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Synovitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Tenosynovitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Trigger Finger</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Breast Cancer</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Prostate Cancer</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Bladder Cancer</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Colon Cancer</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Lung Adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Lung Neoplasm Malignant</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Pancreatic Carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Uterine Leiomyoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Adrenal Adenoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Adrenal Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>B-Cell Lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Basal Cell Carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Benign Gastrointestinal Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Biliary Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Bladder Cancer Recurrent</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Brain Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Breast Cancer Recurrent</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Chronic Lymphocytic Leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Chronic Myeloid Leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Colorectal Cancer Recurrent</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Gallbladder Cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Gastric Cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Glioblastoma Multiforme</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Hepatic Neoplasm Malignant</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Hodgkin's Disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Kaposi's Sarcoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Laryngeal Cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Lipoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Lung Squamous Cell Carcinoma Stage Unspecified</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Lymphocytic Leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Malignant Melanoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Metastases To Bone</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Myeloproliferative Disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Nasal Cavity Cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Neoplasm Prostate</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Peripheral T-Cell Lymphoma Unspecified</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Prostatic Adenoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Rectal Cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Renal Cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Renal Cell Carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Renal Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Skin Cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Thyroid Cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Cerebrovascular Accident</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Transient Ischaemic Attack</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Diabetic Neuropathy</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Carpal Tunnel Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Cerebral Infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Ischaemic Stroke</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Loss Of Consciousness</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Vith Nerve Paralysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Vertebrobasilar Insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Brain Stem Infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Cerebral Ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Diabetic Hyperosmolar Coma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Diabetic Neuropathic Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Embolic Stroke</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Epilepsy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Facial Palsy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Hemiparesis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Ischaemic Cerebral Infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Lumbar Spinal Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Myasthenia Gravis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Neuritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Neuritis Cranial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Partial Seizures</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Radial Nerve Palsy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Spondylitic Myelopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Subarachnoid Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Syncope Vasovagal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Anxiety Disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Depression Suicidal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Generalised Anxiety Disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Major Depression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Renal Colic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Urinary Incontinence</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Bladder Prolapse</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Calculus Ureteric</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Calculus Urethral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Calculus Urinary</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Cystocele</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Diabetic Nephropathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Hydronephrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Nephropathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Renal Failure Acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Stress Urinary Incontinence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Ureteric Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Urinary Retention</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Benign Prostatic Hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Breast Mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Cervical Dysplasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Menorrhagia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Ovarian Cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Pelvic Peritoneal Adhesions</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Postmenopausal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Prostatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Testicular Cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Uterine Polyp</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Vaginal Prolapse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Pulmonary Oedema</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Acute Pulmonary Oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Chronic Obstructive Pulmonary Disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Nasal Polyps</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Nasal Septum Deviation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Pharyngeal Oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Pulmonary Embolism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Pulmonary Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Sleep Apnoea Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Skin Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Angioedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Dermal Cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Diabetic Neuropathic Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Diabetic Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Lichen Planus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Neuropathic Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Sebaceous Hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Femoral Artery Occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Hypertensive Crisis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Aortic Arteriosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Peripheral Vascular Disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Aortic Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Deep Vein Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Extremity Necrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Microangiopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Peripheral Arterial Occlusive Disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Peripheral Ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Varicose Vein</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
              <event>
                <sub_title>Venous Thrombosis Limb</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="953"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA 11.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="50" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="953"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="50" subjects_at_risk="949"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="953"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Niklas Berglind, GPS Atacand</name_or_title>
      <organization>AstraZeneca</organization>
      <phone>+46 31 7766310</phone>
      <email>ClinicalTrialTransparency@astrazeneca.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

